IRX Therapeutics Culture | Comparably
IRX Therapeutics

IRX Therapeutics Company Culture

IRX Therapeutics Culture

This score is derived from employee ratings & reviews

Top Rated Culture Dimensions

IRX Therapeutics CEO

Mark Leuchtenberger IRX Therapeutics' CEO
Mark Leuchtenberger

IRX Therapeutics Company Information

IRX Therapeutics Company Overview

IRX develops immune therapies designed to activate a patient’s immune system to defeat cancer and related diseases.

Headquarter140 West 57th Street, Suite 3D
New York City, NY
United States of America
Websiteirxtherapeutics.com
Tel(212) 582-1199
Company StatusPrivate

IRX Therapeutics CEO & Leadership

IRX Therapeutics CEO - Mark Leuchtenberger

IRX Therapeutics Leadership

  • Mark Leuchtenberger  CEO / President

    Mark Leuchtenberger CEO / President

    Mark Leuchtenberger serves as the CEO / President of IRX Therapeutics.

  • Ron Guido  Vice President Regulatory Affairs

    Ron Guido Vice President Regulatory Affairs

    Ron Guido serves as the Vice President Regulatory Affairs of IRX Therapeutics.

IRX Therapeutics Careers

IRX Therapeutics Jobs

Search

No Recent Jobs found for IRX Therapeutics on Comparably

Mark that you are interested and we will alert you when there are new positions available listed on Comparably

IRX Therapeutics H1B Visa

In 2019, IRX Therapeutics applied for 1 H1B visas. Of the work permits applied for, 100% were approved.

Work Permit Application Outcome

1
Total Applied
  • 100% Granted (1 out of 1)
  • 0% Denied ( out of 1)
  • 0% Withdrawn Application was withdrawn by the employer before approval/rejection ( out of 1)
  • 0% Certified-Withdrawn Application was approved but later withdrawn by employer ( out of 1)

This data was calculated using publicly sourced data from OFLC Performance Data

Let IRX Therapeutics Know You Want To Work There

Frequently Asked Questions regarding IRX Therapeutics

What is IRX Therapeutics address?

IRX Therapeutics location is at 140 West 57th Street, Suite 3D

Who is IRX Therapeutics leadership?

Ron Guido are part of IRX Therapeutics leadership, Mark Leuchtenberger is the CEO

×
Rate your company